Media-OutReach Newswire The Lancet Neurology publishes positive results of AFFiRiS' Phase 1 trial with PD01A in Parkinson’s disease patients
Media-OutReach Newswire Inhibiting Inflammatory Responses, Three Scientists Awarded 2020 Tang Prize in Biopharmaceutical Science
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.